These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9661185)

  • 1. Concern mounts over Munich's BioRegio money.
    Fürst I
    Nat Biotechnol; 1998 Jul; 16(7):614-5. PubMed ID: 9661185
    [No Abstract]   [Full Text] [Related]  

  • 2. Combinatorial chemistry.
    Persidis A
    Nat Biotechnol; 1998 Jul; 16(7):691-3. PubMed ID: 9661206
    [No Abstract]   [Full Text] [Related]  

  • 3. Success in an uneven market.
    Russo E
    Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech-biotech company mergers puzzle investors.
    Dorey E
    Nat Biotechnol; 1998 Jul; 16(7):616. PubMed ID: 9661187
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cost reductions and their effects on drug research].
    Götte D
    Med Klin (Munich); 2005 Jun; 100(6):309-13. PubMed ID: 15968482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial chemistry at the crossroads.
    Whitehead RS
    Nat Biotechnol; 1998 Jan; 16(1):2-3. PubMed ID: 9447574
    [No Abstract]   [Full Text] [Related]  

  • 7. Best-selling human medicines 2002-2004.
    Maggon K
    Drug Discov Today; 2005 Jun; 10(11):739-42. PubMed ID: 15922927
    [No Abstract]   [Full Text] [Related]  

  • 8. NIGMS glue grants.
    Rogers ME
    Pharm Res; 2000 Feb; 17(2):107. PubMed ID: 10751022
    [No Abstract]   [Full Text] [Related]  

  • 9. Harvesting biotechnology.
    Dennis C; Byrne N
    Nature; 2004 Jun; 429(6991 Suppl):1. PubMed ID: 15175703
    [No Abstract]   [Full Text] [Related]  

  • 10. Europe caught in innovation quagmire.
    Mitchell P
    Nat Biotechnol; 2005 Sep; 23(9):1029. PubMed ID: 16151378
    [No Abstract]   [Full Text] [Related]  

  • 11. What's hot in biotech employment.
    Hochberg SP
    Nat Biotechnol; 2001 Apr; 19(4):389. PubMed ID: 11283604
    [No Abstract]   [Full Text] [Related]  

  • 12. Australian biotech suffers growing pains.
    O'Neill G
    Nat Biotechnol; 2005 Apr; 23(4):401-2. PubMed ID: 15815652
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrating information technology and drug discovery processes.
    Bellenson J
    Nat Biotechnol; 1998 Jul; 16(7):597-8. PubMed ID: 9661169
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharma strategies extend drug lives.
    Robertson D
    Nat Biotechnol; 1999 Mar; 17(3):220-1. PubMed ID: 10096280
    [No Abstract]   [Full Text] [Related]  

  • 15. Time for consolidation in Germany.
    Müller C; Rump A
    Nat Biotechnol; 2002 May; 20(5):441-4. PubMed ID: 11981551
    [No Abstract]   [Full Text] [Related]  

  • 16. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.
    Senker J; Enzing C; Joly PB; Reiss T
    Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
    Aguilar A; Bochereau L; Matthiessen-Guyader L
    Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese council urges reform of funding system.
    Triendl R
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract]   [Full Text] [Related]  

  • 19. Norway looks to biotech as the oil starts to run out.
    Hayhurst R
    Drug Discov Today; 2005 Mar; 10(6):387-90. PubMed ID: 15808817
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergen lineage may finally pay off.
    Alper J
    Nat Biotechnol; 1999 Mar; 17(3):217-8. PubMed ID: 10096277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.